Crystal Structures of Fragments D and Double-D from Fibrinogen and Fibrin

Russell F. Doolittle; Glen Spraggon; Stephen J. Everse

doi:10.1055/s-0037-1615842

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1999; 82(02): 271-276
DOI: 10.1055/s-0037-1615842

Research Article

Schattauer GmbH

Crystal Structures of Fragments D and Double-D from Fibrinogen and Fibrin

Russell F. Doolittle

¹Center for Molecular Genetics, University of California, San Diego, Novaritis Institute of Functional Genomics, San Diego, CA, USA, and Department of Biochemistry, University of Vermont School of Medicine, Burlington, VT, USA

,

Glen Spraggon

¹Center for Molecular Genetics, University of California, San Diego, Novaritis Institute of Functional Genomics, San Diego, CA, USA, and Department of Biochemistry, University of Vermont School of Medicine, Burlington, VT, USA

,

Stephen J. Everse

¹Center for Molecular Genetics, University of California, San Diego, Novaritis Institute of Functional Genomics, San Diego, CA, USA, and Department of Biochemistry, University of Vermont School of Medicine, Burlington, VT, USA

› Author Affiliations

Abstract

Introduction

After a long period of anticipation,¹ the last two years have witnessed the first high-resolution x-ray structures of fragments from fibrinogen and fibrin.^2-7 The results confirmed many aspects of fibrinogen structure and function that had previously been inferred from electron microscopy and biochemistry and revealed some unexpected features. Several matters have remained stubbornly unsettled, however, and much more work remains to be done. Here, we review several of the most significant findings that have accompanied the new x-ray structures and discuss some of the problems of the fibrinogen-fibrin conversion that remain unresolved.

* Abbreviations: GPR—Gly-Pro-Arg-derivatives; GPRPam—Gly-Pro-Arg-Pro-amide; GHRPam—Gly-His-Arg-Pro-amide

Full Text

References

References
1 Doolittle RF, Everse SJ, Spraggon G. Human fibrinogen: anticipating a 3-dimensional structure. FASEB J. 1996; 10: 1464-1470.
2 Yee VC, Pratt KP, Cote HC, LeTrong I, Chung DW, Davie EW, Stenkamp RE, Teller DC. Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen. Structure. 1997; 5: 125-138.
3 Pratt KP, Cote HCF, Chung DW, Stenkamp RE, Davie EW. The fibrin polymerization pocket: three-dimensional structure of a 30-kDA C-terminal γ chain fragment complexed with the peptide Gly-Pro-Arg-Pro. Proc Natl Acad Sci USA. 1997; 94: 7176-7181.
4 Spraggon G, Everse S, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 1997; 389: 455-462.
5 Everse SJ, Spraggon G, Veerapandian L, Riley M, Doolittle RF. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry. 1998; 37: 8637-8642.
6 Spraggon G, Applegate D, Everse SJ, Zhang JZ, Veerapandian L, Redman C, Doolittle RF, Grieninger G. Crystal structure of a recombinant extended α^EC domain from human fibrinogen-420. Proc Natl Acad Sci USA 1998; 95: 9099-9104.
7 Everse SJ, Spraggon G, Veerapandian L, Doolittle RF. Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide. Biochemistry 1999; 38: 2941-2946.
8 Shimizu A, Nagel G, Doolittle RF. Photoaffinity labeling of the primary fibrin polymerization site: isolation and characterization of a labeled cyanogen bromide fragment corresponding to γ-chain residues 337-379. Proc Natl Acad Sci USA. 1992; 89: 2287-2892.
9 Yamazumi K, Doolittle RF. Photoaffinity labeling of the primary fibrin polymerization site: localization of the label to γ-chain Tyr-363. Proc Natl Acad Sci USA. 1992; 89: 2893-2896.
10 Donahue JP, Patel H, Anderson WF, Hawiger J. Three-dimensional structure of the platelet integrin recognition segment of the fibrinogen γ chain obtained by carrier protein-driven crystallization. Proc Natl Acad Sci USA. 1994; 92: 12178-12182.
11 Doolittle RF. A detailed consideration of a principal domain of vertebrate fibrinogen and its relatives. Protein Sci. 1992; 1: 1563-1577.
12 Williams RC. Morphology of bovine fibrinogen monomers and fibrin oligomers. J Mol Biol. 1981; 150: 399-408.
13 Weisel JW, Philips GN, Cohen C. A model from electron microscopy for the molecular structure of fibrinogen and fibrin. Nature 1981; 289: 263-267.
14 Rao SPS, Poojary D, Elliot BW, Melanson LA, Oriel B, Cohen C. Fibrinogen structure in projection at 18 Å resolution. electron density by co-ordinated cryo-electron microscopy and X-ray crystallography. J Mol Biol. 1991; 222: 89-98.
15 Weisel JW, Stauffacher CV, Bullitt E, Cohen C. Model for fibrinogen: domains and sequence. Science 1985; 230: 1388-1391.
16 Takagi T, Doolittle RF. Amino acid sequence studies on the a chain of human fibrinogen. Location of four plasmin attack points and a covalent cross-linking site. Biochemistry. 1975; 14: 5149-5156.
17 Doolittle RF, Cassman KG, Cottrell BA, Friezner SJ, Takagi T. Amino acid sequence studies on the α-chain portion of fragment D. Biochemistry. 1977; 16: 1710-1715.
18 Nieuwenhuizen W. Sites in fibrin involved in the acceleration of plasminogen activation by t-PA. Possible role of fibrin polymerization. Thromb Res. 1994; 75: 343-347.
19 Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci USA. 1978; 75: 3085-3089.
20 Laudano AP, Doolittle RF. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry. 1980; 19: 1013-1019.
21 Olexa SA, Budzynski A. Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci USA. 1980; 77: 1374-1378.
22 Hasegawa N, Sasaki S. Location of the binding site “b” for lateral polymerization of fibrin. Thromb Res. 1990; 57: 183-195.
23 Laurent TC, Blomback B. On the significance of the release of two different peptides from fibrinogen during clotting. Acta Chem Scand. 1958; 12: 1875-1977.
24 Weisel JW. Lateral aggregation and the role of the two pairs of fibrinopeptides. Biophys J. 1986; 50: 1079-1093.
25 Weisel JW, Veklich Y, Gorkun O. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J Mol Biol. 1993; 232: 285-297.
26 Weisel JW, Warren SG, Cohen C. Crystals of modified fibrinogen: size, shape and packing of molecules. J Mol Biol. 1978; 126: 159-183.
27 Chen R, Doolittle RF. γ-γ Cross-linking sites in human and bovine fibrin. Biochemistry. 1971; 10: 4486-4491.
28 Haverkate F, Timan G. Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments. Thromb Res. 1977; 10: 803-812.
29 Dang CV, Ebert RF, Bell WR. Localization of a fibrinogen calcium binding site between γ-subunit positions 311 and 336 by terbium fluorescence. J Biol Chem. 1985; 260: 9713-9717.
30 Koopman J, Haverkate F, Briet E, Lord ST. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the γ chain causing defective calcium binding and impaired fibrin polymerization. J Biol Chem. 1991; 266: 13456-13461.
31 Matsuda M. The structure-function relationship of hereditary dysfibrinogens. Int J Hematol. 1996; 64: 167-179.
32 Ebert RF. ed. 1994 Index of variant human fibrinogens. Boca Raton, FL: CRC Press; 1994
33 Everse SJ, Spraggon G, Doolittle RF. A three-dimensional consideration of variant human fibrinogens. Thromb Haemost. 1998; 80: 1-9.
34 Cote HCF, Lord ST, Pratt KP. γ-Chain dysfibrinogenemias: molecular structure-functions relationships of naturally occurring mutations in the γ chain of human fibrinogen. Blood 1998; 92: 2195-2212.
35 Fellowes AP, Brennan SO, Ridgway HJ, Heaton DC, George PM. Electrospray ionization mass spectrometry identification of fibrinogen Banks Peninsula (gamma280Tyr—>Cys): a new variant with defective polymerization. Brit J Haematol. 1998; 101: 24-31.
36 Doolittle R. The evolution of vertebrate fibrinogen. In: Peeters H. ed. Protides of Biological Fluids. H. Oxford: Pergamon Press; 1980: 41-46.
37 Doolittle RF, Spraggon G, Everse SJ. Evolution of vertebrate fibrin formation and the process of its dissolution. In: Bock G, Goode J. eds. Plasminogen-Related Growth Factors. New York, NY: John Wiley & Sons; 1997: 4-17.
38 Selmayr E, Deffner M, Bachmann L, Muller-Berghaus G. Chromatography and electron microscopy of cross-linked fibrin polymers-A new model describing the cross-linking at the DD-trans contact of the fibrin molecules. Biopolymers. 1988; 27: 1733-1748.
39 Mosesson MW, Siebenlist KR, Hainfeld JF, Wall JS. The covalent structure of factor XIII^a crosslinked fibrinogen fibrils. J Struct Biol. 1995; 115: 88-101.
40 Mosesson MW, Siebenlist KR, Meh DA, Wall JS, Hainfeld JF. The location of the carboxy-terminal region of γ chains in fibrinogen and fibrin D domains. Proc Natl Acad Sci USA. 1998; 95: 10511-10515.
41 Gollwitzer R, Bode W, Karges HE. On the aggregation of fibrinogen molecules. Thromb Res. 1983; (Suppl. 05) 41-53.
42 Veklich YI, Gorkun OV, Medved LV, Nieuwenhuizen W, Weisel JW. Carboxyl-terminal portions of the α chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated αC fragments on polymerization. J Biol Chem. 1993; 268: 13577-13585.
43 Gorkun OV, Veklich YI, Medved LV, Henschen AH, Weisel JW. Role of the αC domains of fibrin in clot formation. Biochemistry. 1994; 33: 6986-6997.